Back to Search Start Over

Efficacy and Safety of Vixarelimab, a Human Monoclonal Oncostatin M Receptor Beta Antibody, in Moderate-to-Severe Prurigo Nodularis: A Randomised, Double-Blind, Placebo-Controlled Phase 2a Study

Details

ISSN :
15565068
Database :
OpenAIRE
Journal :
SSRN Electronic Journal
Accession number :
edsair.doi...........5a562312c9ffca0c377b140da2138418
Full Text :
https://doi.org/10.2139/ssrn.4184786